The expanding universe of disorders of the basal ganglia (Q38222396)

31 August 2017

title

The expanding universe of disorders of the basal ganglia (English)

1 reference

Kailash Phatechand Bhatia

31 August 2017

author

series ordinal

4

object named as

Kailash P Bhatia

1 reference

31 August 2017

3

Maria Stamelou

1 reference

31 August 2017

0 references

Jose A Obeso

1

1 reference

31 August 2017

Maria C Rodriguez-Oroz

series ordinal

2

1 reference

31 August 2017

David J Burn

series ordinal

5

1 reference

31 August 2017

language of work or name

English

0 references

publication date

18 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

384

1 reference

31 August 2017

issue

9942

1 reference

31 August 2017

page(s)

523-531

1 reference

PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Motor control in basal ganglia circuits using fMRI and brain atlas approaches

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The striatum and probabilistic implicit sequence learning

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Switching from automatic to controlled behavior: cortico-basal ganglia mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Contributions of the basal ganglia and functionally related brain structures to motor learning

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial reaction time task in rats.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Prospective cohort study of impulse control disorders in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The behavioral spectrum of Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The functional anatomy of Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Future of brain stimulation: new targets, new indications, new technology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

From Jekyll to Hyde after limbic subthalamic nucleus infarction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Cognitive profile of patients with newly diagnosed Parkinson disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

A systematic review of prevalence studies of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Psychosis, apathy, depression and anxiety in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Parkinson's disease motor subtypes and mood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The neuropathological basis for depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Frontal presentation in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Social cognitive deficits and their neural correlates in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Biological markers of cognition in prodromal Huntington's disease: a review.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Neuropsychiatric aspects of treated Wilson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Psychiatric disorders, myoclonus dystonia, and the epsilon‐sarcoglycan gene: A systematic review

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Cognition and psychopathology in myoclonus-dystonia.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The non-motor syndrome of primary dystonia: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Genetics of dystonia: what's known? What's new? What's next?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

THAP1 mutations (DYT6) are an additional cause of early-onset dystonia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Autonomic failures in Perry syndrome with DCTN1 mutation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

FXTAS: new insights and the need for revised diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Parkin disease: a phenotypic study of a large case series

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Nonmotor symptoms in Parkin gene-related parkinsonism.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The endophenotype and the phenotype: temporal discrimination and adult-onset dystonia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

C9orf72 repeat expansions are a rare genetic cause of parkinsonism

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

"Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Recent advances in the genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The link between the GBA gene and parkinsonism

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

Lysosome-dependent pathways as a unifying theme in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

The genetics of Parkinson's disease: progress and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(13)62418-6

7 January 2021

10.1016/S0140-6736(13)62418-6

Identifiers

DOI

1 reference

31 August 2017

1 reference